Clinical Trial Update: A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating antiviral activity and safety of HH-003 in adults with chronic hepatitis B infection and low-level viremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HH-003

Snippet

Sponsor: Huahui Health | Conditions: Chronic HBV Infection | Phase 2 | Status: COMPLETED